Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Li Y et al in Nature Medecine, 2010.
Evaluation of an RNA interference screen-derived mitotic and ceramide pathway meta- gene in paclitaxel-treated primary ER-/PR-/ERBB2- breast cancer: a retrospective analysis of five clinical trials.. Juul N et al in Lancet Oncology, 2010.
Gene expression profiling in breast cancer: Understanding the molecular basis of his- tologic grade to improve prognosis, Sotiriou C et al in Journal of National Cancer Institute, volume 98, pages 262-272, February 2006
A fuzzy gene expression-based computational approach improves breast cancer prog- nostication Haibe-Kains B etal in Genome Biology, 2010.
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Haibe-Kains B et al in Bioinformatics, volume 24, number 19, pages 2200- 2208, July 2008.